Texas 2019 - 86th Regular

Texas Senate Bill SB2267 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 86R16634 KLA-D
22 By: Kolkhorst S.B. No. 2267
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the provision of pharmacy benefits through Medicaid
88 managed care.
99 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1010 SECTION 1. Sections 533.005(a) and (a-2), Government Code,
1111 are amended to read as follows:
1212 (a) A contract between a managed care organization and the
1313 commission for the organization to provide health care services to
1414 recipients must contain:
1515 (1) procedures to ensure accountability to the state
1616 for the provision of health care services, including procedures for
1717 financial reporting, quality assurance, utilization review, and
1818 assurance of contract and subcontract compliance;
1919 (2) capitation rates that ensure the cost-effective
2020 provision of quality health care;
2121 (3) a requirement that the managed care organization
2222 provide ready access to a person who assists recipients in
2323 resolving issues relating to enrollment, plan administration,
2424 education and training, access to services, and grievance
2525 procedures;
2626 (4) a requirement that the managed care organization
2727 provide ready access to a person who assists providers in resolving
2828 issues relating to payment, plan administration, education and
2929 training, and grievance procedures;
3030 (5) a requirement that the managed care organization
3131 provide information and referral about the availability of
3232 educational, social, and other community services that could
3333 benefit a recipient;
3434 (6) procedures for recipient outreach and education;
3535 (7) a requirement that the managed care organization
3636 make payment to a physician or provider for health care services
3737 rendered to a recipient under a managed care plan on any claim for
3838 payment that is received with documentation reasonably necessary
3939 for the managed care organization to process the claim:
4040 (A) not later than:
4141 (i) the 10th day after the date the claim is
4242 received if the claim relates to services provided by a nursing
4343 facility, intermediate care facility, or group home;
4444 (ii) the 30th day after the date the claim
4545 is received if the claim relates to the provision of long-term
4646 services and supports not subject to Subparagraph (i); and
4747 (iii) the 45th day after the date the claim
4848 is received if the claim is not subject to Subparagraph (i) or (ii);
4949 or
5050 (B) within a period, not to exceed 60 days,
5151 specified by a written agreement between the physician or provider
5252 and the managed care organization;
5353 (7-a) a requirement that the managed care organization
5454 demonstrate to the commission that the organization pays claims
5555 described by Subdivision (7)(A)(ii) on average not later than the
5656 21st day after the date the claim is received by the organization;
5757 (8) a requirement that the commission, on the date of a
5858 recipient's enrollment in a managed care plan issued by the managed
5959 care organization, inform the organization of the recipient's
6060 Medicaid certification date;
6161 (9) a requirement that the managed care organization
6262 comply with Section 533.006 as a condition of contract retention
6363 and renewal;
6464 (10) a requirement that the managed care organization
6565 provide the information required by Section 533.012 and otherwise
6666 comply and cooperate with the commission's office of inspector
6767 general and the office of the attorney general;
6868 (11) a requirement that the managed care
6969 organization's usages of out-of-network providers or groups of
7070 out-of-network providers may not exceed limits for those usages
7171 relating to total inpatient admissions, total outpatient services,
7272 and emergency room admissions determined by the commission;
7373 (12) if the commission finds that a managed care
7474 organization has violated Subdivision (11), a requirement that the
7575 managed care organization reimburse an out-of-network provider for
7676 health care services at a rate that is equal to the allowable rate
7777 for those services, as determined under Sections 32.028 and
7878 32.0281, Human Resources Code;
7979 (13) a requirement that, notwithstanding any other
8080 law, including Sections 843.312 and 1301.052, Insurance Code, the
8181 organization:
8282 (A) use advanced practice registered nurses and
8383 physician assistants in addition to physicians as primary care
8484 providers to increase the availability of primary care providers in
8585 the organization's provider network; and
8686 (B) treat advanced practice registered nurses
8787 and physician assistants in the same manner as primary care
8888 physicians with regard to:
8989 (i) selection and assignment as primary
9090 care providers;
9191 (ii) inclusion as primary care providers in
9292 the organization's provider network; and
9393 (iii) inclusion as primary care providers
9494 in any provider network directory maintained by the organization;
9595 (14) a requirement that the managed care organization
9696 reimburse a federally qualified health center or rural health
9797 clinic for health care services provided to a recipient outside of
9898 regular business hours, including on a weekend day or holiday, at a
9999 rate that is equal to the allowable rate for those services as
100100 determined under Section 32.028, Human Resources Code, if the
101101 recipient does not have a referral from the recipient's primary
102102 care physician;
103103 (15) a requirement that the managed care organization
104104 develop, implement, and maintain a system for tracking and
105105 resolving all provider appeals related to claims payment, including
106106 a process that will require:
107107 (A) a tracking mechanism to document the status
108108 and final disposition of each provider's claims payment appeal;
109109 (B) the contracting with physicians who are not
110110 network providers and who are of the same or related specialty as
111111 the appealing physician to resolve claims disputes related to
112112 denial on the basis of medical necessity that remain unresolved
113113 subsequent to a provider appeal;
114114 (C) the determination of the physician resolving
115115 the dispute to be binding on the managed care organization and
116116 provider; and
117117 (D) the managed care organization to allow a
118118 provider with a claim that has not been paid before the time
119119 prescribed by Subdivision (7)(A)(ii) to initiate an appeal of that
120120 claim;
121121 (16) a requirement that a medical director who is
122122 authorized to make medical necessity determinations is available to
123123 the region where the managed care organization provides health care
124124 services;
125125 (17) a requirement that the managed care organization
126126 ensure that a medical director and patient care coordinators and
127127 provider and recipient support services personnel are located in
128128 the South Texas service region, if the managed care organization
129129 provides a managed care plan in that region;
130130 (18) a requirement that the managed care organization
131131 provide special programs and materials for recipients with limited
132132 English proficiency or low literacy skills;
133133 (19) a requirement that the managed care organization
134134 develop and establish a process for responding to provider appeals
135135 in the region where the organization provides health care services;
136136 (20) a requirement that the managed care organization:
137137 (A) develop and submit to the commission, before
138138 the organization begins to provide health care services to
139139 recipients, a comprehensive plan that describes how the
140140 organization's provider network complies with the provider access
141141 standards established under Section 533.0061;
142142 (B) as a condition of contract retention and
143143 renewal:
144144 (i) continue to comply with the provider
145145 access standards established under Section 533.0061; and
146146 (ii) make substantial efforts, as
147147 determined by the commission, to mitigate or remedy any
148148 noncompliance with the provider access standards established under
149149 Section 533.0061;
150150 (C) pay liquidated damages for each failure, as
151151 determined by the commission, to comply with the provider access
152152 standards established under Section 533.0061 in amounts that are
153153 reasonably related to the noncompliance; and
154154 (D) regularly, as determined by the commission,
155155 submit to the commission and make available to the public a report
156156 containing data on the sufficiency of the organization's provider
157157 network with regard to providing the care and services described
158158 under Section 533.0061(a) and specific data with respect to access
159159 to primary care, specialty care, long-term services and supports,
160160 nursing services, and therapy services on the average length of
161161 time between:
162162 (i) the date a provider requests prior
163163 authorization for the care or service and the date the organization
164164 approves or denies the request; and
165165 (ii) the date the organization approves a
166166 request for prior authorization for the care or service and the date
167167 the care or service is initiated;
168168 (21) a requirement that the managed care organization
169169 demonstrate to the commission, before the organization begins to
170170 provide health care services to recipients, that, subject to the
171171 provider access standards established under Section 533.0061:
172172 (A) the organization's provider network has the
173173 capacity to serve the number of recipients expected to enroll in a
174174 managed care plan offered by the organization;
175175 (B) the organization's provider network
176176 includes:
177177 (i) a sufficient number of primary care
178178 providers;
179179 (ii) a sufficient variety of provider
180180 types;
181181 (iii) a sufficient number of providers of
182182 long-term services and supports and specialty pediatric care
183183 providers of home and community-based services; and
184184 (iv) providers located throughout the
185185 region where the organization will provide health care services;
186186 and
187187 (C) health care services will be accessible to
188188 recipients through the organization's provider network to a
189189 comparable extent that health care services would be available to
190190 recipients under a fee-for-service or primary care case management
191191 model of Medicaid managed care;
192192 (22) a requirement that the managed care organization
193193 develop a monitoring program for measuring the quality of the
194194 health care services provided by the organization's provider
195195 network that:
196196 (A) incorporates the National Committee for
197197 Quality Assurance's Healthcare Effectiveness Data and Information
198198 Set (HEDIS) measures;
199199 (B) focuses on measuring outcomes; and
200200 (C) includes the collection and analysis of
201201 clinical data relating to prenatal care, preventive care, mental
202202 health care, and the treatment of acute and chronic health
203203 conditions and substance abuse;
204204 (23) subject to Subsection (a-1) and Section
205205 533.00513, a requirement that the managed care organization
206206 develop, implement, and maintain an outpatient pharmacy benefit
207207 plan for its enrolled recipients:
208208 (A) that exclusively employs the vendor drug
209209 program formulary and preserves the state's ability to reduce
210210 waste, fraud, and abuse under Medicaid;
211211 (B) that adheres to the applicable preferred drug
212212 list adopted by the commission under Section 531.072;
213213 (C) that includes the prior authorization
214214 procedures and requirements prescribed by or implemented under
215215 Sections 531.073(b), (c), and (g) for the vendor drug program;
216216 (D) for purposes of which the managed care
217217 organization:
218218 (i) may not negotiate or collect rebates
219219 associated with pharmacy products on the vendor drug program
220220 formulary; and
221221 (ii) may not receive drug rebate or pricing
222222 information that is confidential under Section 531.071;
223223 (E) that complies with the prohibition under
224224 Section 531.089;
225225 (F) under which the managed care organization may
226226 not prohibit, limit, or interfere with a recipient's selection of a
227227 pharmacy or pharmacist of the recipient's choice for the provision
228228 of pharmaceutical services under the plan through the imposition of
229229 different copayments;
230230 (G) that allows the managed care organization [or
231231 any subcontracted pharmacy benefit manager] to contract with a
232232 pharmacist or pharmacy providers separately for specialty pharmacy
233233 services, except that[:
234234 [(i) the managed care organization and
235235 pharmacy benefit manager are prohibited from allowing exclusive
236236 contracts with a specialty pharmacy owned wholly or partly by the
237237 pharmacy benefit manager responsible for the administration of the
238238 pharmacy benefit program; and
239239 [(ii)] the managed care organization [and
240240 pharmacy benefit manager] must adopt policies and procedures for
241241 reclassifying prescription drugs from retail to specialty drugs,
242242 and those policies and procedures must be consistent with rules
243243 adopted by the executive commissioner and include notice to network
244244 pharmacy providers from the managed care organization;
245245 (H) under which the managed care organization may
246246 not prevent a pharmacy or pharmacist from participating as a
247247 provider if the pharmacy or pharmacist agrees to comply with the
248248 financial terms and conditions of the contract as well as other
249249 reasonable administrative and professional terms and conditions of
250250 the contract;
251251 (I) under which the managed care organization may
252252 include mail-order pharmacies in its networks, but may not require
253253 enrolled recipients to use those pharmacies, and may not charge an
254254 enrolled recipient who opts to use this service a fee, including
255255 postage and handling fees;
256256 (J) under which the managed care organization [or
257257 pharmacy benefit manager, as applicable,] must pay claims in
258258 accordance with Section 843.339, Insurance Code; and
259259 (K) under which the managed care organization [or
260260 pharmacy benefit manager, as applicable]:
261261 (i) to place a drug on a maximum allowable
262262 cost list, must ensure that:
263263 (a) the drug is listed as "A" or "B"
264264 rated in the most recent version of the United States Food and Drug
265265 Administration's Approved Drug Products with Therapeutic
266266 Equivalence Evaluations, also known as the Orange Book, has an "NR"
267267 or "NA" rating or a similar rating by a nationally recognized
268268 reference; and
269269 (b) the drug is generally available
270270 for purchase by pharmacies in the state from national or regional
271271 wholesalers and is not obsolete;
272272 (ii) must provide to a network pharmacy
273273 provider, at the time a contract is entered into or renewed with the
274274 network pharmacy provider, the sources used to determine the
275275 maximum allowable cost pricing for the maximum allowable cost list
276276 specific to that provider;
277277 (iii) must review and update maximum
278278 allowable cost price information at least once every seven days to
279279 reflect any modification of maximum allowable cost pricing;
280280 (iv) must, in formulating the maximum
281281 allowable cost price for a drug, use only the price of the drug and
282282 drugs listed as therapeutically equivalent in the most recent
283283 version of the United States Food and Drug Administration's
284284 Approved Drug Products with Therapeutic Equivalence Evaluations,
285285 also known as the Orange Book;
286286 (v) must establish a process for
287287 eliminating products from the maximum allowable cost list or
288288 modifying maximum allowable cost prices in a timely manner to
289289 remain consistent with pricing changes and product availability in
290290 the marketplace;
291291 (vi) must:
292292 (a) provide a procedure under which a
293293 network pharmacy provider may challenge a listed maximum allowable
294294 cost price for a drug;
295295 (b) respond to a challenge not later
296296 than the 15th day after the date the challenge is made;
297297 (c) if the challenge is successful,
298298 make an adjustment in the drug price effective on the date the
299299 challenge is resolved[,] and make the adjustment applicable to all
300300 similarly situated network pharmacy providers, as determined by the
301301 managed care organization [or pharmacy benefit manager, as
302302 appropriate];
303303 (d) if the challenge is denied,
304304 provide the reason for the denial; and
305305 (e) report to the commission every 90
306306 days the total number of challenges that were made and denied in the
307307 preceding 90-day period for each maximum allowable cost list drug
308308 for which a challenge was denied during the period;
309309 (vii) must notify the commission not later
310310 than the 21st day after implementing a practice of using a maximum
311311 allowable cost list for drugs dispensed at retail but not by mail;
312312 and
313313 (viii) must provide a process for each of
314314 its network pharmacy providers to readily access the maximum
315315 allowable cost list specific to that provider;
316316 (24) a requirement that the managed care organization
317317 and any entity with which the managed care organization contracts
318318 for the performance of services under a managed care plan disclose,
319319 at no cost, to the commission and, on request, the office of the
320320 attorney general all discounts, incentives, rebates, fees, free
321321 goods, bundling arrangements, and other agreements affecting the
322322 net cost of goods or services provided under the plan;
323323 (25) a requirement that the managed care organization
324324 not implement significant, nonnegotiated, across-the-board
325325 provider reimbursement rate reductions unless:
326326 (A) subject to Subsection (a-3), the
327327 organization has the prior approval of the commission to make the
328328 reductions [reduction]; or
329329 (B) the rate reductions are based on changes to
330330 the Medicaid fee schedule or cost containment initiatives
331331 implemented by the commission; and
332332 (26) a requirement that the managed care organization
333333 make initial and subsequent primary care provider assignments and
334334 changes.
335335 (a-2) Except as provided by Subsection (a)(23)(K)(viii), a
336336 maximum allowable cost list specific to a provider and maintained
337337 by a managed care organization [or pharmacy benefit manager] is
338338 confidential.
339339 SECTION 2. Subchapter A, Chapter 533, Government Code, is
340340 amended by adding Section 533.00513 to read as follows:
341341 Sec. 533.00513. PROHIBITED SUBCONTRACTS. A managed care
342342 organization that contracts with the commission under this chapter
343343 to provide health care services to recipients may not contract with
344344 a pharmacy benefit manager for purposes of maintaining an
345345 outpatient pharmacy benefit plan for the organization's enrolled
346346 recipients as required by Section 533.005(a)(23).
347347 SECTION 3. Section 533.012(a), Government Code, is amended
348348 to read as follows:
349349 (a) Each managed care organization contracting with the
350350 commission under this chapter shall submit the following, at no
351351 cost, to the commission and, on request, the office of the attorney
352352 general:
353353 (1) a description of any financial or other business
354354 relationship between the organization and any subcontractor
355355 providing health care services under the contract;
356356 (2) a copy of each type of contract between the
357357 organization and a subcontractor relating to the delivery of or
358358 payment for health care services;
359359 (3) a description of the fraud control program used by
360360 any subcontractor that delivers health care services; and
361361 (4) a description and breakdown of all funds paid to or
362362 by the managed care organization, including a health maintenance
363363 organization, primary care case management provider, [pharmacy
364364 benefit manager,] and exclusive provider organization, necessary
365365 for the commission to determine the actual cost of administering
366366 the managed care plan.
367367 SECTION 4. Section 32.046(a), Human Resources Code, is
368368 amended to read as follows:
369369 (a) The executive commissioner shall adopt rules governing
370370 sanctions and penalties that apply to a provider who participates
371371 in the vendor drug program or is enrolled as a network pharmacy
372372 provider of a managed care organization contracting with the
373373 commission under Chapter 533, Government Code, [or its
374374 subcontractor] and who submits an improper claim for reimbursement
375375 under the program.
376376 SECTION 5. Sections 533.003(b) and 533.056, Government
377377 Code, are repealed.
378378 SECTION 6. (a) The Health and Human Services Commission
379379 shall, in a contract between the commission and a managed care
380380 organization under Chapter 533, Government Code, that is entered
381381 into or renewed on or after the effective date of this Act, require
382382 that the managed care organization comply with Section 533.005,
383383 Government Code, as amended by this Act, and Section 533.00513,
384384 Government Code, as added by this Act.
385385 (b) The Health and Human Services Commission shall seek to
386386 amend contracts entered into with managed care organizations under
387387 Chapter 533, Government Code, before the effective date of this Act
388388 to require those managed care organizations to comply with Section
389389 533.005, Government Code, as amended by this Act, and Section
390390 533.00513, Government Code, as added by this Act. To the extent of
391391 a conflict between those sections and a provision of a contract with
392392 a managed care organization entered into before the effective date
393393 of this Act, the contract provision prevails.
394394 SECTION 7. If before implementing any provision of this Act
395395 a state agency determines that a waiver or authorization from a
396396 federal agency is necessary for implementation of that provision,
397397 the agency affected by the provision shall request the waiver or
398398 authorization and may delay implementing that provision until the
399399 waiver or authorization is granted.
400400 SECTION 8. This Act takes effect September 1, 2019.